Ocular Therapeutix Inc (0OT.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 08:07PM CEST
| Previous close | 7.82 |
| Open | 7.76 |
| Bid | 8.00 x N/A |
| Ask | 8.04 x N/A |
| Day's range | 7.76 - 7.93 |
| 52-week range | 1.88 - 10.51 |
| Volume | |
| Avg. volume | 96 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Wall Street Analysts See an 85.43% Upside in Ocular Therapeutix (OCUL): Can the Stock Really Move This High?
The consensus price target hints at an 85.4% upside potential for Ocular Therapeutix (OCUL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Simply Wall St.
With 65% ownership of the shares, Ocular Therapeutix, Inc. (NASDAQ:OCUL) is heavily dominated by institutional owners
Key Insights Given the large stake in the stock by institutions, Ocular Therapeutix's stock price might be vulnerable...
- Zacks
Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates
Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -9.09% and 3.24%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.